Medtronic reported Q3 earnings per share of $1.45, surpassing estimates of $1.39, and revenue of $9.76 billion, above the $9.55 billion consensus. The strong financial results reflect broad demand for its cardiovascular devices. The company raised its full-year financial outlook, signaling confidence in continued growth. Medtronic is investing over $700 million in innovative platforms like Heart Tech and Robotics, including a new robot surgeon, to drive future technological advancements and growth.
Medtronic reported about 7% organic revenue growth in Q1 FY2027, boosted by new products like pulsed field ablation in its Cardiovascular and Spine divisions. Despite strong sales, margin expansion remains limited as management works to convert growt...
Medtronic increased its quarterly dividend to $0.72 per share, marking a 1.4% raise and extending its dividend increase streak to 49 years. While this steady growth ensures a reliable 2.95% yield, it trails behind faster-growing peers like Abbott and...
